3,4-dihydroxyphenylacetic acid has been researched along with Benign Neoplasms, Brain in 3 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goldstein, DS | 1 |
Sullivan, P | 1 |
Cooney, A | 1 |
Jinsmaa, Y | 1 |
Kopin, IJ | 1 |
Sharabi, Y | 1 |
Lonjon, M | 1 |
Quentien, MH | 1 |
Risso, JJ | 1 |
Michiels, JF | 1 |
Carre, E | 1 |
Rostain, JC | 1 |
Darbin, O | 1 |
von Metzler, A | 1 |
Nitsch, C | 1 |
3 other studies available for 3,4-dihydroxyphenylacetic acid and Benign Neoplasms, Brain
Article | Year |
---|---|
Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Animals; Brain Neoplasms; Dopamine; Electron | 2015 |
Alteration of striatal dopaminergic function induced by glioma development: a microdialysis and immunohistological study in the rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Afferent Pathways; Animals; Brain Neoplasms; Disease Models, Animal; | 2004 |
Monoamine content in rat brain during carcinogenesis and the influence of the CNS drugs piracetam and imipramine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Brain Neoplasms; Caudate Nucleus; Female; | 1985 |